EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potent Anticancer Activity of a Dinuclear Gold(I) bis‐ N ‐Heterocyclic Imine Complex Related to Thioredoxin Reductase Inhibition in Vitro

Mihyun Park iD, Claudia Schmidt iD, Sebastian Türck, Franziska Hanusch iD, Simone V Hirmer, Ingo Ott iD, Angela Casini iD, Shigeyoshi Inoue iD

ChemPlusChem · 2024-04 · 89 (4)

DOI: 10.1002/cplu.202300557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemPlusChem, online erschienen am 29.11.2023. Verfasst von Mihyun Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Technical University of Munich, Lichtenbergstr. 4, 85748, Garching b. München, Germany. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A dinuclear gold(I) complex featuring a strongly donating bis‐ N ‐heterocyclic imine ligand was synthesised and characterised by different methods, including single crystal X‐ray diffraction (SC‐XRD) analysis. The compound has been tested for its antiproliferative effects in a panel of human cancer cell lines in vitro , showing highly selective anticancer effects, particularly against human A549 non‐small cell lung cancer cells (NSCLC), with respect to non‐tumorigenic cells (VERO). The accumulation of the compound in A549 and VERO cells was studied by high‐resolution continuum source atomic absorption spectrometry (HRCS‐AAS), revealing that the anticancer effects are not particularly related to the different amounts of gold taken up by the cells over 72 h. Enzyme inhibition studies to evaluate the activity of the seleno‐enzyme thioredoxin reductase (TrxR) in cancer cell extracts show that the gold(I) compound is a potent inhibitor (IC 50 =0.567±0.208 μM), while the free ligand is ineffective. This result correlates with the observed compound's selectivity towards A549 cells overexpressing the enzyme.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAnimalsChlorocebus aethiopsHumansGoldThioredoxin-Disulfide ReductaseCell Line, TumorLigandsVero Cells

Stichwörter der Autor:innen

antiproliferative activitygoldlung cancermetallodrugsthioredoxin reductase

Substanzen

GoldThioredoxin-Disulfide ReductaseLigands

Autor:innen und Institutionen

  • Department of Chemistry, Technical University of Munich, Lichtenbergstr. 4, 85748, Garching b. München, Germany.
  • Institute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, 38106, Braunschweig, Germany.

ORCID-Profile: Mihyun Park, Claudia Schmidt, Franziska Hanusch, Ingo Ott, Angela Casini, Shigeyoshi Inoue

Zitieren

APA

Park, M., Schmidt, C., Türck, S., Hanusch, F., Hirmer, S. V., Ott, I., Casini, A., & Inoue, S. (2024). Potent Anticancer Activity of a Dinuclear Gold(I) bis‐ N ‐Heterocyclic Imine Complex Related to Thioredoxin Reductase Inhibition in Vitro. ChemPlusChem, 89(4). https://doi.org/10.1002/cplu.202300557

Vancouver

Park M, Schmidt C, Türck S, Hanusch F, Hirmer SV, Ott I, et al. Potent Anticancer Activity of a Dinuclear Gold(I) bis‐ N ‐Heterocyclic Imine Complex Related to Thioredoxin Reductase Inhibition in Vitro. ChemPlusChem. 2024;89(4). doi:10.1002/cplu.202300557

BibTeX
@article{Park2024,
  author = {Park, Mihyun and Schmidt, Claudia and Türck, Sebastian and Hanusch, Franziska and Hirmer, Simone V and Ott, Ingo and Casini, Angela and Inoue, Shigeyoshi},
  title = {Potent Anticancer Activity of a Dinuclear Gold(I) bis‐ N ‐Heterocyclic Imine Complex Related to Thioredoxin Reductase Inhibition in Vitro},
  journal = {ChemPlusChem},
  year = {2024},
  volume = {89},
  number = {4},
  doi = {10.1002/cplu.202300557}
}
Kostenlos starten →